Not logged in...
About USC Norris
FAQ - Trials
Contact Us - Trials
Support USC Norris
» Contact Us
If you are a patient, please contact
Keck Medical Center of USC
HLA-Mismatched Allogeneic Cellular Therapy (HMMACT) After Chemotherapy in High-Risk Acute Myeloid Leukemia.
Open to Accrual
Chemotherapy: Systemic, Other
Defintions of terms and FAQ about clinical trials.
Ann Mohrbacher, M.D.
Other Trial Staff:
Christine Duran, Coordinator, Christine Duran, D.M., Ibrahim Syed, D.M., Ibrahim Syed, Coordinator
to see study documents.
Click here to see trial eligibility criteria and further details at ClinicalTrials.gov
For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or
To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3111.